Dicerna Pharmaceuticals Inc.

(DRNA) Trade

By |

Profile

Dicerna Pharmaceuticals Inc is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. The company is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others.

Contact Information

Website: www.dicerna.com
Email: pschwartz@rxir.com
Main Phone: +1 617 621-8097
Address: 33 Hayden Avenue
State: MA
City / Town: Lexington
Country: US
Postal Code: 02421

Issuer Information

Exchange: NGS
CEO: Douglas M. Fambrough
Employees: 187
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

Profile

Dicerna Pharmaceuticals Inc is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. The company is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others.

Contact Information

Website: www.dicerna.com
Email: pschwartz@rxir.com
Main Phone: +1 617 621-8097
Address: 33 Hayden Avenue
State: MA
City / Town: Lexington
Country: US
Postal Code: 02421

Issuer Information

Exchange: NGS
CEO: Douglas M. Fambrough
Employees: 187
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

$ 18.29 $ -0.56 (-2.97%)
Last Price 18.29 Change $ -0.56 Change % -2.97 Tick N/A
Bid 18.50 Bid Size 500.00 Ask 19.00 Ask Size 500.00
Open 18.62 High 18.98 Low 17.80 Prev Close 18.85
Last Trade Volume 470,517 52 Wk Hi 27.69 52 Wk Low 11.75
Market Cap 1.4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 74,459,045.00 EPS (TTM) -1.77 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 21 38
Number of Buys 3 12
Number of Sells 18 26
Net Activity -558764 12134623
Last 10 Buys Shares
Adam Koppel 1,000
Douglas M. Fambrough 1,000
Douglas M. Fambrough 1,000
James B. Weissman 1,000
James B. Weissman 1,000
James B. Weissman 1,000
Stephen J. Hoffman 1,000
Douglas M. Fambrough 1,000
James B. Weissman 1,000
Last 10 Sell Shares
James B. Weissman 1,000
Bob Brown 1,000
James B. Weissman 1,000
James B. Weissman 1,000
Dennis H. Langer 1,000
John G. Freund 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 18 18 18 18
Low Target Price Estimate 10 10 10 10
Mean Target Price Estimate 14 14 14 14
Standard Deviation 2.61 2.61 2.61 2.61
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 5
Moderate Buy 0 0 0 0
Hold 3 3 3 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.86 1.86 1.86 1.33